Moneycontrol Be a Pro
Get App
Last Updated : Nov 19, 2019 11:37 AM IST | Source:

Hold Cadila Healthcare target of Rs 275: Sharekhan

Sharekhan recommended Hold rating on Cadila Healthcare with a target price of Rs 275 in its research report dated November 14, 2019.

Broker Research @moneycontrolcom
  • bselive
  • nselive
Todays L/H

Sharekhan's research report on Cadila Healthcare

Management has guided for double-digit growth in the U.S. business in 2HFY2020, while India business is expected to grow at a healthy pace. Cadila’s Q2FY2020 results were weak and missed our estimates. We have cut our FY20/FY21 earnings estimates to factor in the same. Though the stock is trading at a reasonable valuation of 15.9x / 14.7x FY20/FY21 estimates, regulatory issues and elevated competition in key product segments is on overhang and would restrict use from taking a constructive view on the stock.


We retain our Hold Recommendation on Cadila Healthcare with an unchanged PT of Rs 275.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on are their own, and not that of the website or its management. advises users to check with certified experts before taking any investment decisions.

LIVE NOW... Video series on How to Double Your Monthly Income... where Rahul Shah, Ex-Swiss Investment Banker and one of India's leading experts on wealth building, reveals his secret strategies for the first time ever. Register here to watch it for FREE.
First Published on Nov 19, 2019 11:37 am
Follow us on
Available On